Tirofiban - CISMeF

Preferred Label : Tirofiban;

MeSH definition : Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME.;

MeSH synonym : N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine;

MeSH hyponym : MK-383; L-700462; L-700,462; L 700,462; L700,462;

MeSH Related Number : 144494-65-5 (Tirofiban); 6H925F8O5J;

Wikipedia link : https://en.wikipedia.org/wiki/Tirofiban;

UNII : GGX234SI5H;

Details

Origin ID

D000077466;

UMLS CUI

C0247025;

ATC code(s)
- tirofiban [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH indexing information
- platelet glycoprotein GPIIb-IIIa complex [MeSH Descriptor]
Pharmacological action(s)
- fibrinolytic agents [MeSH Descriptor]
- platelet aggregation inhibitors [MeSH Descriptor]
Record concept(s)
- Agrastat [MeSH concept]
- L 700462 [MeSH concept]
- MK 383 [MeSH concept]
- aggrastat [MeSH concept]
- tirofiban [MeSH concept]
- tirofiban hydrochloride [MeSH concept]
- tirofiban hydrochloride monohydrate [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients